| | | | | S-ii | | | |
| | | | | S-ii | | | |
| | | | | S-iii | | | |
| | | | | S-iii | | | |
| | | | | S-iv | | | |
| | | | | S-1 | | | |
| | | | | S-4 | | | |
| | | | | S-10 | | | |
| | | | | S-11 | | | |
| | | | | S-12 | | | |
| | | | | S-28 | | | |
| | | | | S-33 | | | |
| | | | | S-35 | | | |
| | | | | S-38 | | | |
| | | | | S-39 | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 27 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 32 | | | |
| | | | | 32 | | |
301 Sylvan Avenue
Englewood Cliffs, NJ 07632
Telephone: (201) 816-8900
Attention: Investor Relations
| | |
As of March 31, 2025
|
| |||||||||
(dollars in thousands)
|
| |
Actual
|
| |
As Adjusted for
the Sale of the Notes |
| ||||||
Long Term Debt | | | | | | | | | | | | | |
Subordinated notes, due 2035(1)
|
| | | $ | — | | | | | $ | | | |
Subordinated notes, due 2030 (net of debt issuance cost of $85)
|
| | | | 74,915 | | | | | | 74,915 | | |
Stockholders’ equity: | | | | | | | | | | | | | |
Preferred Stock, no par value, $1,000 per share liquidation preference;
Authorized 5,000,000 shares; issued 115,000 shares as of March 31, 2025 and as of December 31, 2024; outstanding 115,000 shares as of March 31, 2025 and as of December 31, 2024 |
| | | | 110,927 | | | | | | 110,927 | | |
Common stock, no par value, Authorized 100,000,000 shares; issued 42,355,523 shares as of March 31, 2025 and 42,255,865 shares as of December 31, 2024; outstanding 38,469,975 shares as of March 31, 2025 and 38,370,317 as of December 31, 2024
|
| | | | 586,946 | | | | | | 586,946 | | |
Additional paid-in capital
|
| | | | 36,007 | | | | | | 36,007 | | |
Retained earnings
|
| | | | 643,265 | | | | | | 643,265 | | |
Treasury stock, at cost: 3,885,548 common shares as of March 31, 2025 and
December 31, 2024 |
| | | | (76,116) | | | | | | (76,116) | | |
Accumulated other comprehensive loss
|
| | | | (48,090) | | | | | | (48,090) | | |
Total stockholders’ equity
|
| | | $ | 1,252,939 | | | | | $ | | | |
Capital ratios: | | | | | | | | | | | | | |
Common equity tier 1 to risk-weighted assets
|
| | | | 11.14% | | | | | | % | | |
Tier 1 capital to risk-weighted assets
|
| | | | 12.46% | | | | | | % | | |
Total capital to risk-weighted assets
|
| | | | 14.29% | | | | | | % | | |
Tier 1 leverage to average assets
|
| | | | 11.33% | | | | | | % | | |
Underwriters
|
| |
Amount of
Securities |
| |||
Keefe, Bruyette & Woods, Inc.
|
| | | $ | | | |
Piper Sandler & Co.
|
| | | | | | |
Total
|
| | | $ | | | |
| | |
Per Note
|
| |
Total
|
| ||||||
Public offering price(l)
|
| | | | % | | | | | $ | | | |
Underwriting discounts and commissions paid by us
|
| | | | % | | | | | $ | | | |
Proceeds to us, before expenses
|
| | | | % | | | | | $ | | | |
![[MISSING IMAGE: lg_connectone-4c.jpg]](https://www.sec.gov/Archives/edgar/data/0000712771/000110465925049074/lg_connectone-4c.jpg)
Preferred Stock
Warrants
Debt Securities
Depositary Shares
Units
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 7 | | | |
| | | | | 12 | | | |
| | | | | 14 | | | |
| | | | | 23 | | | |
| | | | | 26 | | | |
| | | | | 27 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 32 | | | |
| | | | | 32 | | |
Attention: Investor Relations
301 Sylvan Avenue
Englewood Cliffs, NJ 07632
(201) 816-8900
![[MISSING IMAGE: lg_connectone-4c.jpg]](https://www.sec.gov/Archives/edgar/data/0000712771/000110465925049074/lg_connectone-4c.jpg)
|
![]() |
| |
![]() |
|